MEDICAL RESEARCH COMMERCIALISATION FUND

The key barrier to translating and commercialising our technologies has been the lack of capital and access to expertise. We also recognised that across Australia and New Zealand, all of the capabilities existed to create a ‘virtual pharmaceutical pipeline powerhouse', but that they weren't connected or coordinated. Our aim was to develop a model that brought together these research and clinical capabilities and partnered them with institutional capital and expertise; thereby overcoming the break in the early stage translation and commercialisation chain, often referred to at the ‘1st Valley of Death'... With this concept on paper and a healthy dose of naïve optimism, in 2007, we managed to convince eight brave medical research institutes in New South Wales and Victoria, supported by those State Governments, to join Brandon BioCatalyst (then known as the Medical Research Commercialisation Fund) when we established our first fund of AUD$30 million... Brandon BioCatalyst is innovation..

Primary location: Melbourne